About Genlight Neurotech
Introduction
Genlight Neurotech was founded in 2020 in Hangzhou, is a sci-tech platform enterprise focused on industrializing cutting-edge technologies in the fields of neuroscience and neurosurgery. The company has established advanced technology platforms in brain-computer interface, medical lasers, and brain-computer chip, providing innovative instrumental solutions for neurological disorders. Developed products include a magnetic resonance-guided laser ablation system, an implantable closed-loop responsive neurostimulation system for epilepsy and Parkinson disease, as well as an SEEG electrode. Two of these products have received breakthrough designation from NMPA.
Genlight Neurotech believes in innovation and cares for the welfare of patients. With a global scope and integration between industry and research, we always strive to be a reliable leader in providing solutions in the neuromedical domain.
Company Patents
Milestones
-
2024
2024
• Epilcure™ selected as "Top 10 Brain-Computer Interface Industry Innovation Cases 2024"
• Zhejiang Provincial High-Tech Enterprise R&D Center
• Zhejiang Specialized and Sophisticated SME
• Zhejiang Most Investment-Worthy Enterprise
• Council Member of National Biomedical Enterprise Platform
-
2023
2023
• Hangzhou Quasi-Unicorn Enterprise
• China Future Unicorn
• Hangzhou Enterprise High-Tech R&D Center
• Top 24 Most Innovative Medical Enterprises in Asia-Pacific
• Series B+ Financing (tens of millions of RMB)
• Genlight & Zhejiang University of Technology Joint R&D Center
• Top 100 Emerging Chinese Medical Device Enterprises
• LaserRO™ passed Innovative Medical Device Special Review (Innovation/Fast Track)
-
2022
2022
• Established "Joint Graduate Training Base" with ZJUT
• Became Council Member of Yuhang District Biomedical Industry Association
• Top 100 Innovative Chinese Medical Devices
• First LaserRO™ clinical trial in China
• LaserRO™ won First Prize in 5th China Medical Device Innovation Competition
• Epilcure™ passed Innovative Medical Device Special Review (Innovation/Fast Track)
• Zhejiang Most Investment-Worthy Innovative Enterprise
-
2021
2021
• Series Pre-A Financing (tens of millions of RMB)
• Acquired Hangzhou Nuowei Medical Technology Co., Ltd.
• Series A Financing (tens of millions of RMB)
• First Epilcure™ clinical implant trial in China
• Epilcure™ multi-center controlled clinical trial launched
• Epilcure™ won First Prize in Semi-finals of 4th China Medical Device Innovation Competition
• Series B Financing (hundreds of millions of RMB)
• Venture50 "New Shoots Top 50" and "Investment Community Healthcare Top 50"
-
2020
2020
• Genlight founded in Yuhang Haichuang Park
• Rated as Key Recommended Overseas High-Level Talent Project by Yuhang District Future Sci-Tech City Management Committee
• Angel Round Financing (3.5 million RMB)
• Second Prize in "Hangzhou Overseas High-Level Talent Innovation and Entrepreneurship Competition"
• LaserRO™ first-generation prototype